Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-octadecanaminium, N,n-dimethyl-n-octadecyl-
2. Ddbas Compound
3. Dimethyl-dioctadecyl-ammonium Bromide
4. Dimethyldioctadecylammonium
5. Dimethyldioctadecylammonium Chloride
6. Dimethyldioctadecylammonium Methyl Sulfate
7. Dimethyldioctadecylammonium Sulfate
8. Dimethyldistearylammonium
9. Dimethyldistearylammonium Bisulfate
10. Dimethyldistearylammonium Bromide
11. Dioctadecyl Dimethylammonium Bromide
12. Dioctadecyldimethylammonium
13. Dioctadecyldimethylammonium Chloride
14. Dioctadecyldimethylammonium Ion
15. Distearyl Dimethyl Ammonium Bromide
16. Distearyldimethylammonium
17. Distearyldimethylammonium Bromide
18. Distearyldimonium
19. Distearyldimonium Chloride
20. Dodab
21. Dsdac Cpd
1. 3700-67-2
2. N,n-dimethyl-n-octadecyloctadecan-1-aminium Bromide
3. 1-octadecanaminium, N,n-dimethyl-n-octadecyl-, Bromide
4. Dimethyl(dioctadecyl)azanium;bromide
5. Distearyldimethylammonium Bromide
6. Distearyl Dimethyl Ammonium Bromide
7. Dioctadecyldimethylammonium Bromide
8. Z5t47r065a
9. 1-octadecanaminium, N,n-dimethyl-n-octadecyl-, Bromide (1:1)
10. Dimethyldistearylammonium Bromide
11. Dsab
12. Einecs 223-037-6
13. Mfcd00041975
14. Unii-z5t47r065a
15. Dimethyldioctadecylazanium Bromide
16. Dsdmab
17. Schembl25636
18. Distearyldimonium Bromide
19. Dtxsid60884005
20. Dimethyl-dioctadecyl-azanium Bromide
21. Dimethyldioctadecylammonium (bromide)
22. Di-n-octadecyldimethylammonium Bromide
23. Akos015833037
24. As-62181
25. Da-17512
26. N,n-distearyl-n,n-dimethylammonium Bromide
27. Bis(octadecyl)dimethylammonium Bromide
28. Cs-0128789
29. D1975
30. Ft-0625134
31. D89966
32. W-106572
33. Q27295043
34. 18:0 Ddab, Dimethyldioctadecylammonium (bromide Salt), Powder
35. 18:0 Ddab, Dimethyldioctadecylammonium (bromide Salt), Chloroform
Molecular Weight | 631.0 g/mol |
---|---|
Molecular Formula | C38H80BrN |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 34 |
Exact Mass | 629.54741 g/mol |
Monoisotopic Mass | 629.54741 g/mol |
Topological Polar Surface Area | 0 Ų |
Heavy Atom Count | 40 |
Formal Charge | 0 |
Complexity | 391 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Surface-Active Agents
Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics. (See all compounds classified as Surface-Active Agents.)
Adjuvants, Immunologic
Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)
Anti-Infective Agents
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
ABOUT THIS PAGE
A Dimethyldioctadecylammonium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dimethyldioctadecylammonium, including repackagers and relabelers. The FDA regulates Dimethyldioctadecylammonium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dimethyldioctadecylammonium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Dimethyldioctadecylammonium supplier is an individual or a company that provides Dimethyldioctadecylammonium active pharmaceutical ingredient (API) or Dimethyldioctadecylammonium finished formulations upon request. The Dimethyldioctadecylammonium suppliers may include Dimethyldioctadecylammonium API manufacturers, exporters, distributors and traders.
click here to find a list of Dimethyldioctadecylammonium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dimethyldioctadecylammonium DMF (Drug Master File) is a document detailing the whole manufacturing process of Dimethyldioctadecylammonium active pharmaceutical ingredient (API) in detail. Different forms of Dimethyldioctadecylammonium DMFs exist exist since differing nations have different regulations, such as Dimethyldioctadecylammonium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Dimethyldioctadecylammonium DMF submitted to regulatory agencies in the US is known as a USDMF. Dimethyldioctadecylammonium USDMF includes data on Dimethyldioctadecylammonium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Dimethyldioctadecylammonium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Dimethyldioctadecylammonium suppliers with USDMF on PharmaCompass.
Dimethyldioctadecylammonium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dimethyldioctadecylammonium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dimethyldioctadecylammonium GMP manufacturer or Dimethyldioctadecylammonium GMP API supplier for your needs.
A Dimethyldioctadecylammonium CoA (Certificate of Analysis) is a formal document that attests to Dimethyldioctadecylammonium's compliance with Dimethyldioctadecylammonium specifications and serves as a tool for batch-level quality control.
Dimethyldioctadecylammonium CoA mostly includes findings from lab analyses of a specific batch. For each Dimethyldioctadecylammonium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dimethyldioctadecylammonium may be tested according to a variety of international standards, such as European Pharmacopoeia (Dimethyldioctadecylammonium EP), Dimethyldioctadecylammonium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dimethyldioctadecylammonium USP).
LOOKING FOR A SUPPLIER?